Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Markovic

Showing results (251-260 of 368) with videos related to

Pageof 37
Sort By:
Clinical Lymphoma & Myeloma|February 28, 2007
AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, Ivana N M Micallef, et al.
JAMA Neurology|September 6, 2017
Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) AntibodiesJustin C Kao, Bing Liao, Svetomir N Markovic, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 27, 2021
<i>BRAF</i> V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)Jessica A Slostad, Minetta C Liu, Jacob B Allred, et al.
Melanoma Research|March 16, 2017
Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanomaRoberto A Leon-Ferre, Lisa A Kottschade, Matthew S Block, et al.
Blood Advances|October 30, 2020
Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiationLaura R E Becher, Wendy K Nevala, Shari Lee Sutor, et al.
Plos One|March 18, 2015
Development and external validation of a prognostic nomogram for metastatic uveal melanomaSara Valpione, Justin C Moser, Raffaele Parrozzani, et al.
Cancer|December 18, 2008
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047ADomingo G Perez, Vera J Suman, Tom R Fitch, et al.
American Journal of Clinical Oncology|December 9, 2008
A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG StudySvetomir N Markovic, Vera J Suman, Wendy K Nevala, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 21, 2025
Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening ResponseMaddi A Jacobson, Yasamin Sharifzadeh, Arkadiusz Z Dudek, et al.
Oncotarget|August 14, 2018
Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot studySvetomir N Markovic, Filippo Galli, Vera J Suman, et al.
Pageof 37

Showing results (251-260 of 368) with videos related to

Sort By:
Pageof 37
Clinical Lymphoma & Myeloma|February 28, 2007
AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, Ivana N M Micallef, et al.
JAMA Neurology|September 6, 2017
Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) AntibodiesJustin C Kao, Bing Liao, Svetomir N Markovic, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 27, 2021
<i>BRAF</i> V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)Jessica A Slostad, Minetta C Liu, Jacob B Allred, et al.
Melanoma Research|March 16, 2017
Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanomaRoberto A Leon-Ferre, Lisa A Kottschade, Matthew S Block, et al.
Blood Advances|October 30, 2020
Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiationLaura R E Becher, Wendy K Nevala, Shari Lee Sutor, et al.
Plos One|March 18, 2015
Development and external validation of a prognostic nomogram for metastatic uveal melanomaSara Valpione, Justin C Moser, Raffaele Parrozzani, et al.
Cancer|December 18, 2008
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047ADomingo G Perez, Vera J Suman, Tom R Fitch, et al.
American Journal of Clinical Oncology|December 9, 2008
A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG StudySvetomir N Markovic, Vera J Suman, Wendy K Nevala, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 21, 2025
Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening ResponseMaddi A Jacobson, Yasamin Sharifzadeh, Arkadiusz Z Dudek, et al.
Oncotarget|August 14, 2018
Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot studySvetomir N Markovic, Filippo Galli, Vera J Suman, et al.
Pageof 37